HAYDEN BRIAN J 4
4 · BONE CARE INTERNATIONAL INC · Filed Jul 1, 2005
Insider Transaction Report
Form 4
Transactions
- Disposition to Issuer
BCII Common Stock
2005-07-01$33.00/sh−75,001$2,475,033→ 0 total - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$11.88/sh−10,000$118,800→ 0 totalExercise: $21.12Exp: 2014-06-22→ BCII Common Stock (10,000 underlying) - Disposition to Issuer
BCII Restricted Stock Units
2005-07-01$33.00/sh−10,000$330,000→ 0 total - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$20.50/sh−75,001$1,537,521→ 0 totalExercise: $12.50Exp: 2013-08-29→ BCII Common Stock (75,001 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock.
- [F2]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per BCII Restricted Stock Unit.
- [F3]Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00.